In a statement published alongside the results, Amgen said: Weight loss had not plateaued by 52 weeks, indicating the potential for further weight reduction. It added that improvements were recorded across other cardiometabolic measures, including waist circumference, blood pressure, high-sensitivity C-reactive protein (hs-CRP) and select lipid parameters
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): a randomized, open-label, multinational, phase 3b trial
Insurance and Cost Considerations: Buying from Affordable Canadian Pharmacy The 2026 financial landscape for Wegovy has shifted due to the TrumpRx federal pricing initiative and expanded Medicare coverage for cardiovascular indications
Heather Jefferies
Neuroinflammation and Brain Health Emerging research suggests that semaglutide might cross the blood-brain barrier and provide neuroprotective effects
Establish this eating pattern early because you will rely on it heavily during months two and three when side effects peak